Delivery Order SPE2DB20D1109-SPE2DB25FP19F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,061.28 to supply Cervidil 10 mg vaginal inserts, with an ultimate completion date of October 29, 2025. The contract, awarded on October 28, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.90 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 9, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This is a firm fixed-price, competitive award with no set-aside designation, issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,637.68 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of December 19, 2025. This is a firm fixed-price, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with performance completed by September 10, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. The award...
- The Defense Logistics Agency awarded a $1,353.76 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts under a firm fixed-price contract. The award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation, and performance will be completed at the...
- This delivery order, awarded September 14, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Cervidil 10 mg vaginal inserts with a firm fixed price ceiling value of $5,886.42 and an ultimate completion date of September 15, 2025. The contract represents a non-set-aside award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a ceiling value of $5,415.04 under a firm fixed-price contract type. The contract carries an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,707.52 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. The contract, which is a child order under a larger vehicle, carries a firm fixed price structure with no set-aside designation and was competitively awarded. The ultimate completion date is June 3, 2025, with performance to be fulfilled at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order as part of its extensive federal medical procurement portfolio serving...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP19FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.44 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This contract, awarded on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Cervidil (dinoprostone) is a synthetic prostaglandin used in obstetric care for cervical ripening and labor induction. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains extensive experience fulfilling DLA medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The competitively awarded delivery order reflects the company's established capability to meet federal healthcare needs through the flexible IDC framework, which supports customers including the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/6/25 |